Merits of Continuous Paravertebral Block in the Management of Renal/Adrenal Surgery by Laparotomy (BPV)

Regional University Hospital Center (CHRU)

Status: Terminated

Conditions: Indication for Renal and/or Adrenal Surgery

Treatments: Procedure: Continuous Paravertebral block

Study type: Interventional

Funder types: Other

Identifiers

NCT01023854

BPV

RB 09.011 (Registry Identifier)

Details and patient eligibility

About

The paravertebral block is an alternative in the analgesia epidural the major interest of which lives in the catheterisation of the paravertébral space allowing to assure/insure an one-sided continuous analgesia.

The main objective of the study is to bring to light the superiority of the continuous paravertébral block, as a supplement to analgesia, in the care of the renal and\or adrenal surgery by laparotomy at the adult in terms of consumption of morphine, with regard to the classic analgesia classic.

The main assessment criterion is the consumption of morphine within first 24 postoperative hours at the patients benefiting from a paravertébral continuous block besides the classic systematic analgesia.

Enrollment: 41 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age > 18 years
• Patient scheduled for renal and/or adrenal surgery
• American Society of Anesthesiologists score ASA I, II, III
• Written informed consent given by the patient

Exclusion criteria

• Contraindication in the loco-regional anesthesia in the products of local anesthetic
• Surgery as a matter of urgency
• Pregnancy
• Congestive Cardiac insufficiency
• Severe hepatic Incapacity
• Disturbs of the coagulation
• Age < 18 years
• ASA IV
• Patient already participating in a study or deadline 3-month-old subordinate since the end of a previous study
• Under guardianship Patient
• Psychiatric pathology or limitation of the intellectual abilities making difficult the understanding of the subjective questions.

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

41 participants in 2 patient groups, including a placebo group

Continuous Paravertebral block

Experimental group

Description:

Continuous Paravertebral block

Treatment:

Procedure: Continuous Paravertebral block

Placebo

Placebo Comparator group

Description:

Placebo

Treatment:

Procedure: Continuous Paravertebral block